Gene ID Number
1ug per 1ul
Human, Mouse, Rat
ALEXA FLUOR® 350
Purified by Protein A.
Alexa Fluor,ALEXA FLUOR 350
Conjugated Primary Antibodies
Rabbit (Oryctolagus cuniculus)
Angiotensin II type 1A receptor
Anti-Angiotensin II type 1A receptor PAb ALEXA FLUOR 350
Angiotensin II type 1A receptor Antibody, ALEXA FLUOR 350 Conjugated
This is a highly specific antibody against Angiotensin II type 1A receptor.
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
AT1; AG2S; AT1B; AT1R; AT1AR; AT1BR; AT2R1; HAT1R; AGTR1B; Type-1 angiotensin II receptor; Angiotensin II type-1 receptor; AGTR1; AGTR1A; AT2R1B
Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human of human Angiotensin II type 1A receptor
Store this antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Keep refrigerated at 2 to 8 degrees Celcius for up to one year.
For facs or microscopy Alexa 1 conjugate.Alexa Fluor 350 conjugates can be used in multi-color flow cytometry with FACS's equipped with a second red laser or red diode.If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies. ALEXA FLUOR they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.